Longevity Stack

The Longevity Stack's power lies in its multi-pronged attack on cellular ageing mechanisms. Each peptide addresses different aspects of the ageing process, creating a synergistic effect that's greater than the sum of its parts.

MOTS-c serves as the metabolic optimiser, enhancing mitochondrial function and improving cellular energy production. Research suggests it helps maintain muscle function, supports healthy glucose metabolism, and may improve exercise capacity—all crucial for healthy ageing. Its mitochondrial-targeting properties make it an ideal foundation for any longevity protocol.

SS-31 (also known as Elamipretide) complements MOTS-c perfectly by protecting mitochondria from oxidative damage. Whilst MOTS-c optimises function, SS-31 acts as a guardian, concentrating in the inner mitochondrial membrane to prevent lipid peroxidation and maintain membrane integrity. Studies demonstrate its protective effects against age-related mitochondrial dysfunction.

Epithalon operates at the genetic level, potentially supporting telomerase activity and DNA repair mechanisms. Early research indicates it may help maintain telomere length—the protective caps on chromosomes that shorten with age. This makes it the perfect complement to the mitochondrial-focused peptides, addressing ageing from both cellular energy and genetic stability perspectives.

Together, these peptides create a comprehensive anti-ageing approach: MOTS-c optimises cellular energy, SS-31 protects against damage, and Epithalon supports genetic maintenance. This trinity addresses three fundamental pillars of healthy ageing.

MOTS-c Protocol: Recommended dose: 5-10mg, 2-3 times weekly Timing: Morning or pre-workout for optimal metabolic benefits Injection: Subcutaneous (rotate sites: abdomen, thigh) Cycle: 8-12 weeks, followed by 4-week break

SS-31 Protocol: Recommended dose: 2.5-5mg daily Timing: Morning administration preferred Injection: Subcutaneous, can be co-administered with MOTS-c Cycle: Continuous use for 12 weeks, then 2-week break

Epithalon Protocol: Recommended dose: 5-10mg daily for 10-20 days Timing: Evening administration may be optimal Injection: Subcutaneous or intramuscular Cycle: 2-3 cycles yearly, typically every 3-6 months

Administration Notes: All peptides require reconstitution with bacteriostatic water—use our reconstitution guide for proper preparation. Store reconstituted peptides in the refrigerator and use within 28 days. Rotate injection sites to prevent irritation and maintain sterile technique throughout.

Sample Weekly Schedule:

• Monday: MOTS-c (morning) + SS-31 (morning)
• Tuesday: SS-31 only
• Wednesday: MOTS-c + SS-31
• Thursday: SS-31 only
• Friday: MOTS-c + SS-31
• Weekend: SS-31 only

Add Epithalon during designated cycle periods (2-3 times yearly). Consider using our cost calculator to budget for your protocol effectively.

Weeks 1-2: Initial adaptation phase with minimal noticeable effects. Some users report improved sleep quality (particularly with evening Epithalon cycles) and slight increases in morning energy levels. SS-31 may provide subtle improvements in recovery from physical activity.

Weeks 3-4: Metabolic improvements become more apparent. MOTS-c users often report enhanced exercise performance, better glucose regulation after meals, and more stable energy throughout the day. The protective effects of SS-31 become more noticeable with improved recovery times.

Month 2: Synergistic effects begin to manifest. Many users report improved skin appearance, better stress tolerance, and more consistent sleep patterns. Muscle recovery and overall vitality typically show marked improvement. Cognitive clarity may enhance due to improved mitochondrial function.

Month 3 and beyond: Long-term benefits emerge, including potential improvements in metabolic markers, enhanced physical performance, and better stress resilience. Users often report feeling more youthful overall. The cumulative effects of improved mitochondrial function and cellular protection become most apparent during this phase, with many choosing to continue protocols long-term with appropriate cycling breaks.

The Longevity Stack is generally well-tolerated, but individual responses vary. Common side effects include mild injection site reactions (redness, swelling) that typically resolve within 24-48 hours.

MOTS-c: Potential fatigue during initial adaptation, mild nausea if administered without food, temporary changes in appetite regulation. Some users report increased energy that may affect sleep if injected late in the day.

SS-31: Rare reports of mild headaches or dizziness during first week of use. Some users experience slight changes in blood pressure—monitor if you have cardiovascular concerns.

Epithalon: Generally considered the safest option with minimal reported side effects. Occasional reports of vivid dreams during cycle periods, likely due to improved sleep quality.

Contraindications: Avoid if pregnant, breastfeeding, or under 21 years. Those with active cancer should consult healthcare providers before use, as enhanced cellular function could theoretically affect all cell types. Individuals with cardiovascular conditions should monitor blood pressure regularly.

UK Legal Considerations: These peptides exist in a legal grey area for personal use. Review our UK peptide legality guide for current regulations. Purchase only from reputable suppliers and ensure products are for research purposes. Always consult healthcare providers before beginning any peptide protocol, particularly if you have underlying health conditions.